Live Presentation and Q&A: Tuesday, July 28, 2026 12 PM EDTKing of Prussia, Pennsylvania--(Newsfile Corp. - July 22, 2026) -...
SHANGHAI, July 21, 2026 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading...
Record Share Volume Reflects Strong Market Interest in Diversified AI and Revenue-Generating Operations MESA, AZ / ACCESS Newswire / July...
Brings extensive experience in patient care, dermatologic research and commercializationKing of Prussia, Pennsylvania--(Newsfile Corp. - July 21, 2026) - Phio...
Subsidiaries Infinite Auctions and Real Game Used Deliver Revenue Momentum While MDCE Advances Melanoma Scan Beta and Wound Monitoring Initiatives...
Internal Testing Demonstrates Strong Technical Progress and Positions MDCE for Growth in AI-Powered Preventive Wellness MESA, AZ / ACCESS Newswire...
Securing additional patent protection in the United States, Canada, and Japan for INTASYL CompoundsKing of Prussia, Pennsylvania--(Newsfile Corp. - July...
Infinite Auctions and Real Game News Deliver Tangible Results and Non-Dilutive Funding for Core Technology Initiatives MESA, AZ / ACCESS...
Iconic LeBron, Kobe, and Iverson Game Worn Items Headline Event Generating Non-Dilutive Capital for Operations and Technology Development MESA, AZ...
Connecticut's largest vitreoretinal practice joins the growing AllyGPO and BioCareSD retina network, bringing significant scale, clinical depth, and an enduring...
Medical Care Technologies, Inc. (OTC PINK:MDCE) Details Six-Phase Internal Testing Protocol Driving Melanoma Scan Beta Progress MESA, AZ / ACCESS...
Rapid Internal Innovation Renders U.S. Provisional Patent Application No. 63/854,935 Obsolete, Highlighting Exceptional Velocity in AI Development MESA, AZ /...
Internal Testing Yields Encouraging Results Slightly Above Industry Benchmarks for AI Skin Lesion Analysis Tools MESA, AZ / ACCESS Newswire...
Provides broad overview of Company's research and early development programs expected to continue to fuel future growthHighlights validation of T-cell...
Live virtual fireside chat - investors, advisors, and life sciences analysts invited to attendKing of Prussia, Pennsylvania--(Newsfile Corp. - June...
Nitto Denko Avecia begins first commercial-scale cGMP production of PH-762 drug substanceNewly manufactured supply will support upcoming clinical trial in...
The Company invites individual and institutional investors, as well as advisors and analysts with an interest in Phio Pharmaceuticals, to...
Company discusses secure image handling, privacy-focused platform architecture, and future compliance-oriented development initiatives MESA, AZ / ACCESS Newswire / June...
Company initiates structured internal testing focused on platform stability, workflow optimization, and image consistency evaluation MESA, AZ / ACCESS Newswire...
Novel genomics-enabled clinical trial in United Arab Emirates (UAE) seeks to identify genetic predictors of treatment response while evaluating Teverelix® as...